Improving a patient's quality of life by managing pain and other distressing symptoms of a serious illness is what those in hospice and palliative medicine do each day. Being able to address all types of pain across all settings and for diverse populations, while also managing the risk for diversion and misuse, requires a delicate balance that the experts within CO*RE are uniquely suited to provide.

- Ron Crossno, MD, family medicine physician, and palliative medicine specialist

The mission of CO*RE is to promote individual and population health and public safety through timely, evidence-based, outcome-oriented and interprofessional education related to the comprehensive management of pain, addiction, and their co-morbidities.

Primary care providers, pain management, addiction and palliative care specialists, and clinicians representing all arenas of the health care system struggle to successfully manage their patients' pain. For many patients, long-acting and extended-release opioid medications constitute an effective and valuable element in the pain management plan. However, opioid prescription involves many complex issues of misuse, abuse, addiction, adverse effects, and fear of legal and regulatory action. In order to address risk and safety concerns, reduce serious adverse outcomes, and simultaneously ensure that pain patients maintain necessary access to opioids, the U. S. Food and Drug Administration (FDA) has developed a Risk Evaluation and Mitigation Strategy (REMS) that applies to all long-acting and extended-release opioid medications.

The educational activities of CO*RE and its member organizations, including this website, are supported by an independent educational grant from the ER/LA Opioid Analgesics REMS Program Companies (RPC). Please see www.er-la-opioidREMS.com for a listing of the member companies.

Menu Search